FDA decision on bladder cancer treatment Vicinium on Feb 16th, 2021. If approved, it's looking like SESN has a shot at breaking the $3.00 mark.
And of course, Massachusetts-based stocks always get a thumbs up from me dawg 👍
NASDAQ:GPRO showing a bounded, but upward trend ahead of earnings . Likely will report strong growth and sales from the '20 holiday period, though guidance is uncertain and may depend on the success of the COVID vaccine rollout. As we head into the spring season, if there's a return to outdoor activities, GPRO will do well. Anecdotally, the HERO9 is getting...
